DeepMed Research

University Of Pittsburgh

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1787-02-28

Employees: 10K

Market Cap: -

Website: http://www.pitt.edu

Clinical Trials

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1

Withdrawn

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-04-20

Last Posted Date: 2013-12-19

Lead Sponsor: University of Pittsburgh

Registration Number: NCT00009815

Gene Therapy in Treating Patients With Advanced Head and Neck Cancer

Phase 1

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-04-02

Last Posted Date: 2016-02-12

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 13

Registration Number: NCT00009841

Locations: 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

Knee Stability Training for Knee Osteoarthritis (OA)

Phase 2

Completed

Conditions: Osteoarthritis
Joint Diseases

Interventions: Other: Knee stability training
Other: Traditional exercise therapy for knee osteoarthritis

First Posted Date: 2004-03-04

Last Posted Date: 2013-01-24

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 231

Registration Number: NCT00078624

Locations: 🇺🇸
University of Pittsburgh, Department of Physical Therapy, School of Health and Rehabilitation Sciences, Pittsburgh, Pennsylvania, United States

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Phase 1

Completed

Conditions: Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Pancreatic Cancer

First Posted Date: 2004-02-20

Last Posted Date: 2016-01-18

Lead Sponsor: University of Pittsburgh

Registration Number: NCT00003411

Locations: 🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

Phase 1

Withdrawn

Conditions: Bladder Cancer

First Posted Date: 2004-01-07

Last Posted Date: 2013-12-19

Lead Sponsor: University of Pittsburgh

Registration Number: NCT00014287

Treating Behavioral Disturbances in Individuals With Dementia

Phase 2

Completed

Conditions: Dementia

First Posted Date: 2003-12-03

Last Posted Date: 2014-03-10

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 137

Registration Number: NCT00073658

Locations: 🇺🇸
University of Pittsburgh Medical Center/Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States

Treatment of Depression in Adults

Phase 4

Completed

Conditions: Depression

Interventions: Behavioral: Interpersonal Psychotherapy
Other: Escitalopram plus IPT
Drug: Escitalopram

First Posted Date: 2003-12-03

Last Posted Date: 2012-01-11

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 290

Registration Number: NCT00073697

Locations: 🇺🇸
Western Psychiatric Institute and Clinic - Depression Prevention Program, Pittsburgh, Pennsylvania, United States
🇮🇹
The University of Pisa, Pisa, Italy

Epidemiology of Coronary Heart Disease in Men Aged 40 and Over

Completed

Conditions: Heart Diseases
Coronary Disease
Atherosclerosis
Coronary Arteriosclerosis
Cardiovascular Diseases

First Posted Date: 2003-10-06

Last Posted Date: 2013-01-15

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 1027

Registration Number: NCT00069797

Locations: 🇺🇸
130 North Bellefield Avenue, Suite 546, Pittsburgh, Pennsylvania, United States

Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-09-04

Last Posted Date: 2013-12-19

Lead Sponsor: University of Pittsburgh

Registration Number: NCT00008086

Locations: 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2003-06-06

Last Posted Date: 2015-03-30

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 22

Registration Number: NCT00010231

Locations: 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy